Evidence map›Paper›PMID 36523418›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for

Fariborz Mansour-Ghanaei, Behnam Masihipour, Mohammad Fathalipour, Soheil Hassanipour, Homayoon Sokhanvar, Alireza Mansour-Ghanaei, Mehrnaz Asgharnezhad, Farahnaz Joukar

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Advances in the Management of RefractoryGastro hep advances · 2026
    Review
  2. Review
  3. An Update on Eradication ofMiddle East journal of digestive diseases · 2024
    Review
  4. The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy forEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fariborz Mansour-GhanaeiCaspian Digestive Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0001-6747-0232
Behnam MasihipourGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0003-1867-6992
Mohammad FathalipourDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.ORCID https://orcid.org/0000-0002-4568-7024
Soheil HassanipourGI Cancer Screening and Prevention Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0002-6661-4908
Homayoon SokhanvarGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0001-5490-7837
Alireza Mansour-GhanaeiGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0002-8260-0506
Mehrnaz AsgharnezhadCaspian Digestive Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0002-0409-3852
Farahnaz JoukarGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0001-8432-8879
Guilan University of Medical Sciences · IRHormozgan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of microbial resistance is growing, and new rescue regimens are needed to treat

Identifiers

PMID36523418
PMCPMC9747295
OpenAlexW4311658390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.